Stock Analysts’ Price Target Changes for October 8th (ABBV, ACAD, ALNY, APLD, AR, AVBP, AXSM, BIIB, BMY, CVI)

Stock Analysts’ price target changes for Thursday, October 8th:

AbbVie (NYSE:ABBV) had its target price raised by Cantor Fitzgerald from $285.00 to $290.00. They currently have an overweight rating on the stock.

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its price target lowered by Royal Bank Of Canada from $37.00 to $36.00. They currently have an outperform rating on the stock.

Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target reduced by Royal Bank Of Canada from $350.00 to $345.00. Royal Bank Of Canada currently has an outperform rating on the stock.

Applied Digital (NASDAQ:APLD) had its target price cut by Needham & Company LLC from $83.00 to $70.00. Needham & Company LLC currently has a buy rating on the stock.

Antero Resources (NYSE:AR) had its target price lowered by Mizuho from $57.00 to $51.00. Mizuho currently has an outperform rating on the stock.

ArriVent BioPharma (NASDAQ:AVBP) had its target price trimmed by HC Wainwright from $47.00 to $27.00. They currently have a buy rating on the stock.

Axsome Therapeutics (NASDAQ:AXSM) had its target price reduced by Royal Bank Of Canada from $297.00 to $295.00. They currently have an outperform rating on the stock.

Biogen (NASDAQ:BIIB) had its target price trimmed by Royal Bank Of Canada from $260.00 to $256.00. The firm currently has an outperform rating on the stock.

Bristol Myers Squibb (NYSE:BMY) had its target price cut by Cantor Fitzgerald from $59.00 to $53.00. The firm currently has a neutral rating on the stock.

CVR Energy (NYSE:CVI) had its target price increased by Mizuho from $29.00 to $52.00. The firm currently has an underperform rating on the stock.

Camping World (NYSE:CWH) had its target price lowered by KeyCorp from $9.00 to $8.00. The firm currently has an overweight rating on the stock.

Cytokinetics (NASDAQ:CYTK) had its price target increased by Royal Bank Of Canada from $112.00 to $113.00. The firm currently has an outperform rating on the stock.

HF Sinclair (NYSE:DINO) had its target price raised by Mizuho from $85.00 to $119.00. Mizuho currently has a neutral rating on the stock.

Elmet Group (NASDAQ:ELMT) had its target price raised by Needham & Company LLC from $25.00 to $28.00. Needham & Company LLC currently has a buy rating on the stock.

Exelixis (NASDAQ:EXEL) had its price target lowered by Royal Bank Of Canada from $46.00 to $45.00. They currently have a sector perform rating on the stock.

Flutter Entertainment (NYSE:FLUT) had its price target trimmed by Wedbush from $126.00 to $110.00. Wedbush currently has an outperform rating on the stock.

First Solar (NASDAQ:FSLR) had its price target cut by The Goldman Sachs Group, Inc. from $310.00 to $272.00. The firm currently has a buy rating on the stock.

FrontView REIT (NYSE:FVR) had its target price reduced by BMO Capital Markets from $24.00 to $20.00. The firm currently has an outperform rating on the stock.

Graham (NYSE:GHM) had its price target trimmed by Oppenheimer Holdings, Inc. from $130.00 to $115.00. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.

Gilead Sciences (NASDAQ:GILD) had its price target boosted by Royal Bank Of Canada from $123.00 to $126.00. They currently have a sector perform rating on the stock.

Healthcare Services Group (NASDAQ:HCSG) had its target price cut by Robert W. Baird from $26.00 to $24.00. The firm currently has a neutral rating on the stock.

Harworth Group (LON:HWG) had its target price cut by Berenberg Bank from GBX 195 to GBX 187. Berenberg Bank currently has a hold rating on the stock.

Iovance Biotherapeutics (NASDAQ:IOVA) had its price target boosted by Robert W. Baird from $6.00 to $11.00. They currently have a neutral rating on the stock.

Gartner (NYSE:IT) had its price target boosted by Morgan Stanley from $177.00 to $182.00. They currently have an equal weight rating on the stock.

Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target reduced by Royal Bank Of Canada from $299.00 to $296.00. Royal Bank Of Canada currently has an outperform rating on the stock.

KKR & Co. Inc. (NYSE:KKR) had its price target cut by Barclays PLC from $135.00 to $130.00. The firm currently has an overweight rating on the stock.

Knight-Swift Transportation (NYSE:KNX) had its target price boosted by Stifel Nicolaus from $88.00 to $90.00. The firm currently has a buy rating on the stock.

Lincoln International (NYSE:LCLN) had its price target cut by Morgan Stanley from $28.00 to $27.00. Morgan Stanley currently has an equal weight rating on the stock.

Legend Biotech (NASDAQ:LEGN) had its price target trimmed by Royal Bank Of Canada from $58.00 to $56.00. Royal Bank Of Canada currently has an outperform rating on the stock.

Levi Strauss & Co. (NYSE:LEVI) had its price target lowered by Barclays PLC from $27.00 to $26.00. The firm currently has an overweight rating on the stock.

Levi Strauss & Co. (NYSE:LEVI) had its target price lowered by Wells Fargo & Company from $25.00 to $20.00. The firm currently has an equal weight rating on the stock.

LGN (NASDAQ:LGN) had its target price reduced by Stifel Nicolaus from $101.00 to $82.00. Stifel Nicolaus currently has a buy rating on the stock.

Eli Lilly and Company (NYSE:LLY) had its target price boosted by Cantor Fitzgerald from $1,410.00 to $1,440.00. They currently have an overweight rating on the stock.

Lamb Weston (NYSE:LW) had its price target raised by Stephens from $50.00 to $55.00. The firm currently has an equal weight rating on the stock.

Moelis & Company (NYSE:MC) had its price target trimmed by Morgan Stanley from $85.00 to $77.00. They currently have an overweight rating on the stock.

McDonald’s (NYSE:MCD) had its price target trimmed by Sanford C. Bernstein from $295.00 to $250.00. The firm currently has a market perform rating on the stock.

Mirum Pharmaceuticals (NASDAQ:MIRM) had its target price raised by Royal Bank Of Canada from $135.00 to $155.00. The firm currently has an outperform rating on the stock.

MiniMed Group (NASDAQ:MMED) had its price target raised by Mizuho from $26.00 to $28.00. The firm currently has an outperform rating on the stock.

Marathon Petroleum (NYSE:MPC) had its target price raised by Mizuho from $304.00 to $457.00. The firm currently has a neutral rating on the stock.

Merck & Co., Inc. (NYSE:MRK) had its price target increased by Cantor Fitzgerald from $120.00 to $145.00. They currently have a neutral rating on the stock.

Netflix (NASDAQ:NFLX) had its target price reduced by Morgan Stanley from $83.00 to $80.00. Morgan Stanley currently has an overweight rating on the stock.

BeOne Medicines (NASDAQ:ONC) had its target price boosted by Royal Bank Of Canada from $450.00 to $459.00. The firm currently has an outperform rating on the stock.

OSI Systems (NASDAQ:OSIS) had its target price reduced by Oppenheimer Holdings, Inc. from $300.00 to $265.00. They currently have an outperform rating on the stock.

On the Beach Group (LON:OTB) had its price target cut by Berenberg Bank from GBX 280 to GBX 240. They currently have a buy rating on the stock.

Everpure (NYSE:P) had its price target increased by Needham & Company LLC from $150.00 to $185.00. Needham & Company LLC currently has a buy rating on the stock.

Patrick Industries (NASDAQ:PATK) had its target price cut by KeyCorp from $115.00 to $100.00. KeyCorp currently has an overweight rating on the stock.

PBF Energy (NYSE:PBF) had its price target raised by Mizuho from $65.00 to $89.00. Mizuho currently has a neutral rating on the stock.

Pfizer (NYSE:PFE) had its target price increased by Cantor Fitzgerald from $27.00 to $28.00. Cantor Fitzgerald currently has a neutral rating on the stock.

Regeneron Pharmaceuticals (NASDAQ:REGN) had its target price raised by Royal Bank Of Canada from $737.00 to $810.00. Royal Bank Of Canada currently has a sector perform rating on the stock.

RPM International (NYSE:RPM) had its target price trimmed by Deutsche Bank Aktiengesellschaft from $126.00 to $115.00. The firm currently has a buy rating on the stock.

Sunrun (NASDAQ:RUN) had its price target cut by The Goldman Sachs Group, Inc. from $13.00 to $11.00. The firm currently has a buy rating on the stock.

Revolution Medicines (NASDAQ:RVMD) had its target price raised by Royal Bank Of Canada from $251.00 to $259.00. Royal Bank Of Canada currently has an outperform rating on the stock.

SailPoint (NASDAQ:SAIL) had its price target raised by Robert W. Baird from $22.00 to $25.00. The firm currently has an outperform rating on the stock.

Saratoga Investment (NYSE:SAR) had its price target trimmed by B. Riley Financial, Inc. from $22.00 to $20.00. They currently have a neutral rating on the stock.

Shoals Technologies Group (NASDAQ:SHLS) had its target price boosted by Barclays PLC from $10.00 to $11.00. They currently have an overweight rating on the stock.

Sequans Communications (NYSE:SQNS) had its target price reduced by Roth Capital from $20.00 to $15.00. They currently have a buy rating on the stock.

Sarepta Therapeutics (NASDAQ:SRPT) had its price target reduced by Royal Bank Of Canada from $19.00 to $17.00. They currently have a sector perform rating on the stock.

Constellation Brands (NYSE:STZ) had its price target lowered by Needham & Company LLC from $185.00 to $150.00. Needham & Company LLC currently has a buy rating on the stock.

Constellation Brands (NYSE:STZ) had its target price cut by Morgan Stanley from $158.00 to $145.00. The firm currently has an equal weight rating on the stock.

Valero Energy (NYSE:VLO) had its target price raised by Mizuho from $300.00 to $434.00. They currently have a neutral rating on the stock.

Vishay Intertechnology (NYSE:VSH) had its price target increased by Oppenheimer Holdings, Inc. from $42.00 to $45.00. The firm currently has an outperform rating on the stock.

Wayfair (NYSE:W) had its price target raised by Robert W. Baird from $116.00 to $117.00. They currently have a neutral rating on the stock.

Werner Enterprises (NASDAQ:WERN) had its target price increased by Stifel Nicolaus from $40.00 to $42.00. Stifel Nicolaus currently has a hold rating on the stock.